Print Page     Close Window     

SEC Filings

DEFM14A
ASTERIAS BIOTHERAPEUTICS, INC. filed this Form DEFM14A on 02/04/2019
Entire Document
 

 

 

ASTERIAS BIOTHERAPEUTICS, INC.
STATEMENTS OF COMPREHENSIVE LOSS
(IN THOUSANDS)

 

   Years Ended December 31, 
   2017   2016   2015 
NET LOSS  $(28,372)  $(35,489)  $(15,003)
Other comprehensive income/(loss):               
Unrealized (loss)/gain on available-for-sale securities, net of tax   (5,927)   (1,512)   937 
Reclassification of realized loss on available-for-sale securities, net of taxes   508         
Total other comprehensive income/(loss)   (5,419)   (1,512)   937 
COMPREHENSIVE LOSS  $(33,791)  $(37,001)  $(14,066)

 

The accompanying notes are an integral part of these financial statements.

 

 F-5 

© Copyright BioTime, Inc.